抗毒蕈碱药物治疗膀胱过度活动症的研究进展
摘要
膀胱过度活动症（Overactive Bladder，OAB）是一种慢性疾病，抗毒蕈碱药物作为主要的治疗手段一直备受关注，关于此类药物的研究主要集中在阐明其作用机制，如何合理用药以及新药的研发。本文将对近几年关于抗毒蕈碱药物研究的现状及进展作一综述。
出处
《国际泌尿系统杂志》
2010年第3期342-345,共4页
International Journal of Urology and Nephrology
参考文献28
-
1Abrams P,Cardozo L,Fall M,et al.The standardisation of terminology of lower urinary tract function report from the standardisation subcommittee of the International Continence Society.Neurourol Urodyn,2002,21:167-178.
-
2Zorba OU,Kocak T,Onetn K.Overactive Bladder Syndrome and Detrusor Overactivity:Is There a Strong Relation between the Symptoms and Urodynamic Findings? Turk j Med Sci,2009,39(2):267-272.
-
3Irwin DE,Milsom I,Hunskaar S,et al.Population-based survey of urinary incontinence,overactive bladder,and other lower urinary tract symptoms in five countries:results of the EPIC study.Eur Urol,2006,50:1306-1315.
-
4Yoahida M,Inadome A,Maeda Y,et al.Non-neuronal cholinergic system in human bladder urothelium.Urology,2006,67:425-430.
-
5Mansfield KJ.Chandran JJ,Vanx KJ.et al.Comparison of receptor binding characteristics of commonly used muscarinic antagonists in human bladder detrusor and mucosa.J Pharmacol Exp Ther,2009,328:893-899.
-
6Chess-Williams R.Muscarinic receptors of the urinary bladder:detrusor,urothelial and prejunctional.Auton Autacoid Pharmacol,2002,22:133-145.
-
7Grol S,Essers PBM.Van Koeveringe GA.et al.M3 muscarinic receptor expression on suburothelial interstitial cells.BJU Int,2009,104:398-405.
-
8Kachur JF,Peterson JS,Carter JP,et al.Renantiomers and Senantiomers of oxybutynin:pharmacological effects in guinea pigbladder and intestine.J Pharmacol Exp Ther,1988,247:867-872.
-
9De Laet K,De Wachter S.Wyndaele JJ.Systemic oxybutynin decreases afferent activity of the pelvic nerve of the rat:new insights into the working mechanism of antimuscarinics.Neurourol Urodyn,2006,25:156-161.
-
10Lijima K,De Wachter S,Wyndaele JJ.Effects of the M3 receptor selective muscarinic antagonist darifenacin on bladder afferent activity of the rat pelvic nerve.Eur Urol,2007,52:842-849.
-
1滕若冰,梁月有,郑克立.M2、M3受体与膀胱逼尿肌关系的研究进展[J].国际泌尿系统杂志,2006,26(5):676-681. 被引量：9
-
2邱建宏,滑丽美,赵新鸿,张世睿,孟晓东,马际尧,吴英,李刚.抗毒蕈碱药物联合阿米替林和中药治疗女性膀胱疼痛综合征[J].临床误诊误治,2012,25(12):81-83. 被引量：1
-
3宋波.膀胱肌源性兴奋异常在膀胱过度活动症发病机制中的作用及意义[J].中华医学杂志,2013,93(42):3329-3330. 被引量：11
-
4吴卫红,江波涛,邹伟.卫喜康联合针灸治疗女性膀胱过度活动症33例临床观察[J].湖北科技学院学报（医学版）,2013,27(1):36-38. 被引量：6
-
5杨康,邹媛,喻俊峰.肾缺血再灌注损伤发生机制及治疗进展[J].海南医学,2017,28(2):275-277. 被引量：9
-
6关志忱,周锦棠.膀胱过度活动症膀胱内药物治疗[J].中华泌尿外科杂志,2007,28(1):68-70. 被引量：12
-
7李茂华,孙霆.女性膀胱过度活动症42例临床分析[J].中国计划生育和妇产科,2009,1(4):50-51.
-
8杨欣.膀胱过度活动症的诊断与治疗[J].中国实用妇科与产科杂志,2007,23(11):894-896. 被引量：7
-
9王东文,双卫兵.膀胱过度活动症[J].临床泌尿外科杂志,2005,20(7):445-447. 被引量：8
-
10叶雄俊.随机、双盲安慰剂对照研究评价抗毒蕈碱制剂Solifenacin治疗膀胱过度活动症的疗效[J].中华泌尿外科杂志,2005,26(3):216-216.
